Literature DB >> 15205738

[The 80 W potassium-titanium-phosphate (KTP) laser vaporization of the prostate. Technique and 6 month follow-up after 70 procedures].

A Bachmann1, O Reich, St Wyler, R Ruszat, R Casella, T Gasser, A Hofstetter, T Sulser.   

Abstract

BACKGROUND: Despite good efficacy, even in our days, TURP remains a potentially difficult procedure to perform and is associated with significant risks for the patient. Several alternatives have been tried to reduce the known perioperative morbidity. We report our first experiences with 80 W potassium titanyl phosphate (KTP) laser vaporization of the prostate in patients with symptomatic BPH. PATIENTS AND METHODS: In 70 patients 80 W KTP laser vaporization was performed successfully. Mean age was 70.5 years (46-93 years) and mean transrectal prostate volume was 48.1 ml (10-250 ml).
RESULTS: Mean operating time was 41 min ( n=22), 64 min ( n=33), and 80 min ( n=15) for a 26 ml, 46 ml, and a 91 ml prostate, respectively. At time of discharge, after 1 month, and 6 months the urinary peak flow increased by 75.4%, 166.8%, and 168.6%, respectively.
CONCLUSION: The 80 W KTP laser vaporization of the prostate combines the tissue-debulking properties of transurethral resection of the prostate with the known good hemostatic properties of other laser procedures. It is a safe procedure for the patient and provides a virtually bloodless operation and immediate improvement of voiding.

Entities:  

Mesh:

Year:  2004        PMID: 15205738     DOI: 10.1007/s00120-004-0622-6

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  29 in total

Review 1.  Transurethral resection of the prostate: the new old standard.

Authors:  Joe O Littlejohn; Mohamed A Ghafar; Young M Kang; Steven A Kaplan
Journal:  Curr Opin Urol       Date:  2002-01       Impact factor: 2.309

2.  The 'band electrode': first experiences with a novel TURP procedure to improve hemostasis.

Authors:  P Faul; G Farin; O Reich; U Steude
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

3.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

Authors:  N P Roos; J E Wennberg; D J Malenka; E S Fisher; K McPherson; T F Andersen; M M Cohen; E Ramsey
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

4.  Hybrid laser treatment compared with transurethral resection of the prostate for symptomatic bladder outlet obstruction caused by a large benign prostate: a prospective, randomized trial with a 6-month follow-up.

Authors:  K Tuhkanen; A Heino; M Alaopas
Journal:  BJU Int       Date:  1999-11       Impact factor: 5.588

5.  Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines.

Authors:  R S Kuntzman; R S Malek; D M Barrett; D G Bostwick
Journal:  Urology       Date:  1996-10       Impact factor: 2.649

6.  Low-power v high-power KTP laser: improved method of laser ablation of prostate.

Authors:  W B Shingleton; F Terrell; L Renfroe; J Kolski; J E Fowler
Journal:  J Endourol       Date:  1999-02       Impact factor: 2.942

7.  The "Wedge" resection device for electrosurgical transurethral prostatectomy.

Authors:  A P Perlmutter; D A Schulsinger
Journal:  J Endourol       Date:  1998-02       Impact factor: 2.942

8.  A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia.

Authors:  R S Cowles; J N Kabalin; S Childs; H Lepor; C Dixon; B Stein; A Zabbo
Journal:  Urology       Date:  1995-08       Impact factor: 2.649

9.  Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.

Authors:  Charles Y Pak; Howard J Heller; Margaret S Pearle; Clarita V Odvina; John R Poindexter; Roy D Peterson
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

10.  Transurethral resection of the prostate for benign prostatic hypertrophy: factors associated with a successful outcome at 1 year.

Authors:  H A Doll; N A Black; K McPherson
Journal:  Br J Urol       Date:  1994-06
View more
  6 in total

Review 1.  [GreenLight laser vaporisation of the prostate for treatment of benign prostatic hyperplasia. Development and significance].

Authors:  H-H Seifert; T Hermanns; T Sulser
Journal:  Urologe A       Date:  2008-08       Impact factor: 0.639

2.  [Functional outcome after laser vaporisation of the prostate with the KTP laser].

Authors:  M F Hamann; C Wild; C Seif; S Hautmann; K P Jünemann; P M Braun
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

3.  [Benign prostatic syndrome (BPS). Ablative treatments].

Authors:  O Reich; M Seitz; C Gratzke; B Schlenker; A Bachmann; C Stief
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

4.  [Photoselective vaporization of the prostate: experience with prostate adenomas >80 cm3].

Authors:  R Ruszat; S Wyler; H-H Seifert; O Reich; T Forster; C G Stief; T Sulser; A Bachmann
Journal:  Urologe A       Date:  2006-07       Impact factor: 0.639

Review 5.  [Benign prostatic hyperplasia (BPH) : Surgical therapy options].

Authors:  O Reich; M Seitz; C Gratzke; B Schlenker; S Walther; C Stief
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

Review 6.  Lasers in clinical urology: state of the art and new horizons.

Authors:  Andrew J Marks; Joel M H Teichman
Journal:  World J Urol       Date:  2007-03-28       Impact factor: 3.661

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.